Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of targeted cancer therapies. It exhibits strong activity against tyrosine kinases involved in tumor growth and angiogenesis. Its structure enables high selectivity and binding affinity, making it valuable in pharmaceutical research for treating solid tumors and hematological malignancies. Also employed in structure-activity relationship (SAR) studies to optimize drug potency and reduce off-target effects.